Fresh analysis reveals that people who come off new slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle programs.
Research printed in a major health publication demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping.
"Individuals using such drugs need to be cognizant of the danger of fast weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
This pace of regain means a return to original mass within about one and a half years.
Comparing Therapies
The study, which examined 37 of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with older methods.
Scientists emphasize that people who shed pounds through dieting generally see a more gradual weight regain—around 0.1 kg a month—once they finish.
Understanding the Quick Regain
Doctors suggest the mode of action of the injections is key to understanding the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating far more likely."
A Lifelong Issue?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts contend that, given the significant potential of weight regain, the treatment might need to be life-long.
This perspective is reinforced by drug manufacturers, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like diabetes.
User Experiences
People who have discontinued the jabs explain a sudden resurgence of appetite.
"It felt as if a trigger activating and you're instantly ravenous," described a patient.
This difficulty is compounded if users have not established sustainable lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that millions of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Adoption is higher among females than men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on ongoing lifestyle support.
